Please use this identifier to cite or link to this item:
https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/759
Title: | Valproate in dementia: time to move on? Commentary on…Cochrane Corner |
Authors: | Dhindsa, Amreek Medical Trainee |
Keywords: | Dementia |
Issue Date: | Feb-2019 |
Citation: | Amreek Dhindsa. Valproate in dementia: time to move on? Commentary on…Cochrane Corner. Advances (2019), vol. 25, 145–149 doi: 10.1192/bja.2019.8 |
Abstract: | Baillon et al ’s Cochrane review included 430 participants with agitation in dementia from five randomised controlled trials. Overall, the reviewers found that valproate was no better than placebo for the treatment of agitation in people with dementia; however, the quality of the studies included was very variable. Adverse effects and events were higher in the treatment group compared with the controls, although these finding were largely based on low-quality data with incomplete reporting; thus, valproate’s safety profile is of concern. This review demonstrates that there is insufficient evidence to change current treatment guidelines. |
Description: | The article attached to this record is the Author(s) pre-/post- print version only. NOTE: this is not the version published in BJPsych Advances. Minor changes may have been made for publication. Eligible users can access the full text via NHS OpenAthens (login required) |
URI: | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/759 |
Appears in Collections: | Dementia BJPsych Advances publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Amreek Dhindsa Valproate-Dementia.pdf | PrePrint | 245.36 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.